A mouse model for the study of transplanted bone marrow mesenchymal stem cell survival and proliferation in lumbar spinal fusion
Bone marrow aspirate has been successfully used alongside a variety of grafting materials to clinically augment spinal fusion. However, little is known about the fate of these transplanted cells. Herein, we develop a novel murine model for the in vivo monitoring of implanted bone marrow cells (BMCs) following spinal fusion.
A clinical-grade scaffold was implanted into immune-intact mice undergoing spinal fusion with or without freshly isolated BMCs from either transgenic mice which constitutively express the firefly luciferase gene or syngeneic controls. The in vivo survival, distribution and proliferation of these luciferase-expressing cells was monitored via bioluminescence imaging over a period of 8 weeks and confirmed via immunohistochemistry. MicroCT imaging was performed 8 weeks to assess fusion.
Bioluminescence imaging indicated transplanted cell survival and proliferation over the first 2 weeks, followed by a decrease in cell numbers, with transplanted cell survival still evident at the end of the study. New bone formation and increased fusion mass volume were observed in mice implanted with cell-seeded scaffolds.
By enabling the tracking of transplanted bone marrow-derived cells during spinal fusion in vivo, this mouse model will be integral to developing a deeper understanding of the biological processes underlying spinal fusion in future studies.
KeywordsSpinal fusion Mouse model Bone marrow Luciferase Mesenchymal stem cell
Work in the Spinal Fusion Laboratory is supported by The Gordon and Marilyn Macklin Foundation and the AO Foundation (Grant No. S-16-59H).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Kitchel SH (2006) A preliminary comparative study of radiographic results using mineralized collagen and bone marrow aspirate versus autologous bone in the same patients undergoing posterior lumbar interbody fusion with instrumented posterolateral lumbar fusion. Spine J 6:405–411. https://doi.org/10.1016/j.spinee.2005.09.013 CrossRefPubMedPubMedCentralGoogle Scholar
- 2.Neen D, Noyes D, Shaw M et al (2006) Healos and bone marrow aspirate used for lumbar spine fusion: a case controlled study comparing healos with autograft. Spine (Phila Pa 1976) 31:E636–E640. https://doi.org/10.1097/01.brs.0000232028.97590.12 CrossRefGoogle Scholar
- 14.Lina IA, Puvanesarajah V, Liauw JA et al (2014) Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis. Spine (Phila Pa 1976) 39:347–355. https://doi.org/10.1097/brs.0000000000000169 CrossRefGoogle Scholar
- 21.Todeschi MR, El Backly R, Capelli C et al (2015) Transplanted umbilical cord mesenchymal stem cells modify the in vivo microenvironment enhancing angiogenesis and leading to bone regeneration. Stem Cells Dev 24:1570–1581. https://doi.org/10.1089/scd.2014.0490 CrossRefPubMedPubMedCentralGoogle Scholar